-
1 Comment
Shanghai Haohai Biological Technology Co., Ltd is currently in a long term uptrend where the price is trading 87.6% above its 200 day moving average.
From a valuation standpoint, the stock is 94.0% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 6.8.
Shanghai Haohai Biological Technology Co., Ltd's total revenue rose by 2.0% to $831M since the same quarter in the previous year.
Its net income has increased by 7.6% to $203M since the same quarter in the previous year.
Finally, its free cash flow grew by 276.3% to $89M since the same quarter in the previous year.
Based on the above factors, Shanghai Haohai Biological Technology Co., Ltd gets an overall score of 5/5.
| CurrencyCode | HKD |
|---|---|
| ISIN | CNE100001W69 |
| Sector | Healthcare |
| Industry | Biotechnology |
| Exchange | HK |
| PE Ratio | 13.15 |
|---|---|
| Target Price | 42.1045 |
| Dividend Yield | 6.3% |
| Market Cap | 12B |
| Beta | 0.58 |
Shanghai Haohai Biological Technology Co., Ltd. engages in the research, development, manufacture, and sale of biomedical materials in China, Europe, the United States, and internationally. The company offers ophthalmology products consisting intraocular lens, medical sodium hyaluronate gel, and lubricant eye drop. It also offers sodium hyaluronate injection, medical chitosan, sodium hyaluronate gel, sodium hyaluronate gel, anti adhesion, and burn wound related products. In addition, the company provides injectors, scalpels, and suture needles. Further, it offers medical aesthetics products comprising Matrifill, a first-generation hyaluronic acid (HA) dermal filler, which is a mono-phase sodium hyaluronate gel for injection; Janlane, a second-generation HA dermal filler for dynamic filling function; Hyalumatrix, a third-generation HA dermal filler that offers precise embellishment function; genetic-engineering preparations for epidermal repair; and radio frequency devices and laser equipment. Additionally, the company is involved in the research and development of biological engineering and pharmaceutical products, as well as in the provision of related technology transfer, and consultation services; sale of professional life and home cosmetology machines; and manufacture and sale of biological reagents, biologicals and biological materials, and other machines and accessories. The company was formerly known as Haohai Limited and changed its name to Shanghai Haohai Biological Technology Co., Ltd. in 2010. Shanghai Haohai Biological Technology Co., Ltd. was founded in 2007 and is headquartered in Shanghai, China.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 6826.HK using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
